DEF: UFP Technologies Sets June 4th Annual Meeting

UFP Technologies announces its 2026 Annual Meeting of Stockholders will be a virtual event on June 4th, focusing on director elections, executive compensation, and auditor ratification.

Summary

• UFP Technologies, Inc. will hold its Annual Meeting of Stockholders virtually on June 4, 2026, at 10:00 a.m. Eastern Daylight Time.
• The meeting agenda includes the election of seven directors, a non-binding advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• The record date for determining stockholders entitled to vote is April 10, 2026.
• Proxy materials are expected to be mailed to stockholders on or about May 4, 2026.
• Stockholders can attend and vote online by visiting the provided webcast link and entering their control number.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to strong corporate governance, exceeding performance targets for compensation, and a smooth CEO transition plan. The high CEO pay ratio is noted but contextualized.

Positives

• The company maintains a strong corporate governance framework with 85.7% independent director nominees and 100% independent board committees.
• All directors stand for election annually, and the company does not have a shareholder rights plan (poison pill).
• A Lead Independent Director is appointed to preside over executive sessions of independent directors, ensuring active oversight.
• The company has a Clawback Policy in place.
• Board Committee Charters and Corporate Governance Guidelines are reviewed annually.
• The company's executive compensation program is designed to align with business strategies and encourage stockholder value creation, with a significant portion tied to performance.
• Over 80% of stockholders approved executive compensation on an advisory basis in the previous year, indicating support for current compensation policies.

Negatives

• The CEO pay ratio is notably high at 1,031:1, although this is significantly influenced by the inclusion of lower-wage employees from Costa Rica and the Dominican Republic. Excluding these employees, the ratio drops to 163:1.

Risks

• The filing does not explicitly detail new or heightened risks beyond standard operational and market risks inherent in the manufacturing sector.
• Potential risks related to the transition of the CEO role, though mitigated by a planned phased approach and experienced leadership.

Future Outlook

The filing primarily concerns the upcoming annual meeting and does not contain specific forward-looking financial guidance. However, it details the election of directors who will guide the company's future strategy and the ratification of auditors who will oversee financial reporting.

Management Comments

• Effective June 4, 2026, Mr. Bailly will retire from his position as the Chief Executive Officer of the Company. If elected to serve as a director at the 2026 Annual Meeting of Stockholders, Mr. Bailly will serve as Executive Chairman of the Board.
• The Board believes the separation of the Executive Chairman and Chief Executive Officer roles allows the Chief Executive Officer to focus his time and energy on operating and managing and leverage the experience and perspectives of the Executive Chairman, particularly in Mr. Rock's first year of transition into that role.
• We value the opinions of our stockholders and will consider the outcome of the vote when making future compensation decisions.
• The Audit Committee has considered whether the provision of non-audit services by Grant Thornton is compatible with maintaining Grant Thornton's independence and believes that the provision of such services is compatible.

Industry Context

StockSavvy.ai notes that UFP Technologies operates in the contract development and manufacturing sector for single-use and single-patient medical devices, a vital link in the medical device supply chain. The company's ability to compete effectively relies on attracting and retaining key management personnel, which is supported by its competitive compensation structure.

Comparison to Industry Standards

• The company's peer group for compensation benchmarking in 2025 included companies such as Avanos Medical, Inc., Integer Holdings Corporation, Orthofix Medical, Inc., 10X Genomics, Inc., Atrivion, Inc., Azenta, Inc., Alphatec Holdings, Inc., AtriCure, Inc., Glaukos Corporation, Haemonetics Corporation, Inari Medical, Inc. (now Stryker), CONMED Corporation, iRhythm Technologies, Inc., Integra Life Sciences Holding Corp., STAAR Surgical Company, Sotera Health Company, Transmedics Group, Inc., Novanta, Inc., and Osi Systems, Inc.
• The company aims to position executive compensation at or about the 50th percentile compared to its peer group.
• Director compensation includes a retainer of $210,000 ($60,000 cash, $150,000 equity), which is competitive within the industry for similar roles and company sizes.
• The company's corporate governance practices, such as a high percentage of independent directors and independent board committees, align with best practices in the industry.

Management Changes

Corporate Governance

Related Party Transactions

• In fiscal 2025, John Bailly (brother of R. Jeffrey Bailly) received approximately $216,292 in compensation for services as Director, Corporate Estimating.

Stakeholder Impact

• Shareholders: The election of directors and advisory vote on executive compensation directly impact shareholder interests and corporate direction. The ratification of the auditor ensures financial reporting integrity.
• Management and Employees: The compensation details and the CEO transition plan provide clarity on executive rewards and leadership succession.
• Auditors: The ratification of Grant Thornton LLP confirms their continued role in auditing the company's financial statements.

Next Steps

• Stockholders to vote on the election of seven directors.
• Stockholders to vote on the nonbinding advisory resolution to approve the compensation of named executive officers.
• Stockholders to ratify the appointment of Grant Thornton LLP as the independent registered public accounting firm.
• R. Jeffrey Bailly to transition from CEO to Executive Chairman of the Board on June 4, 2026.
• Mitchell C. Rock to assume the role of Chief Executive Officer on June 4, 2026.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new financial performance data or significant strategic shifts that would warrant a buy or sell recommendation. The information provided is standard for corporate governance and executive compensation disclosures. The planned CEO transition is noted, but the company's performance and outlook are not detailed in this document to support a stronger recommendation.

Keywords

UFP Technologies, Annual Meeting, Proxy Statement, Stockholders, Director Election, Executive Compensation, Auditor Ratification, Virtual Meeting, Corporate Governance, Grant Thornton LLP